Mangalam Drugs & Organics Q1, Q2, Q3, Q4, FY 2016-17, FY 2015-16 Standalone / Consolidated Results, Revenues, Net Profit, Tax, EPS, Live Chart …

Mangalam Drugs & Organics Company Profile :

Mangalam Drugs and Organics Limited is an Indian company engaged in the business of manufacturing of drugs, medicines and allied products.

Company also manufactures active pharmaceutical ingredients (APIs), intermediates and specialty chemicals.

Company has a range of products that involves various chemistries, including Acylations, Polymoph Transformations, Chlorination and Hydride Reductions.


Mangalam Drugs & Organics ResultsBSE Code : 532637
NSE Symbol :  MANGALAM
ISIN No. : INE584F01014
Industry : Pharmaceuticals
Face Value : Rs. 10.00


If you are an investor who has shares of Mangalam Drugs & Organics or you are an stock market analyst then i am sure you might for Quarterly Results of Mangalam Drugs & Organics.

In this article you will find Q1, Q2, Q3, Q4 and FY 2016-17 Results of Mangalam Drugs & Organics . That’s not all, you can compare those results with previous year i.e., FY 2015-16 Results of Mangalam Drugs & Organics .

Mangalam Drugs & Organics Q1 Results 2016-17 :

Mangalam Drugs & Organics will announce its Q1 FY 2016-17 Results in the month of July 2016. We will update the table below once the results are announced.

(Values in Cr.) Q1 Standalone Q1 Consolidated
Revenue
Other Income  –
Total Income
Expenditure  –
Interest  –
Depreciation
PBT
Tax  –
Net Profit  –
Equity  –
EPS  –

Mangalam Drugs & Organics will announce its Q2 FY 2016-17 Results in the month of October 2016.

Mangalam Drugs & Organics will announce its Q3 FY 2016-17 Results in the month of January 2017.

Mangalam Drugs & Organics will announce its Q4 FY 2016-17 Results in the month of April 2017.

Mangalam Drugs & Organics will announce its FY 2016-17 Results in the month of April 2017.

Note : We will update the results table above as and when results are announced. Visit again.

Mangalam Drugs & Organics Previous Year’s Results (FY 2015-16) :

(Values in Cr.) Standalone Consolidated
Revenue 295.16
Other Income  0.02
Total Income  295.18  –
Expenditure  -257.46  –
Interest  -9.29  –
Depreciation  -4.41  –
PBT  24.02  –
Tax  -7.98
Net Profit  16.03
Equity  14.38
EPS  11.15  –

Note : If you like this information about Mangalam Drugs & Organics Quarterly Results, then please share it with all your friends, relatives and other investors on Facebook, Twitter, WhatsApp, Email, etc.